カテゴリ： 世界, 医療/バイオ, QYResearch

人工皮膚マトリックスの世界市場2023年：動物由来、ヒト由来

■ 英語タイトル：Global Artificial Dermal Matrix Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7632）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7632
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：115
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[人工皮膚マトリックスの世界市場2023年：動物由来、ヒト由来]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は人工皮膚マトリックスのグローバル市場について調査・分析し、世界の人工皮膚マトリックス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（動物由来、ヒト由来）、用途別セグメント分析（病院、診療所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、MTF Biologics、Allosource、Parametrics Medical、LifeNet Health、Gunze、Tissue Regenix、Zimmer Biomet、Integra LifeSciences、Organogenesis、Flower Orthopedics、Promethean、Wright Medical Group、Aziyo Biologics、RTI Surgical、MiMedx Group、Tides Medical、Ventris Medical、Vivex Biomedical、Aedicell、Amniox Medical、StimLabs、Skye Biologicsなどが含まれています。人工皮膚マトリックスのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、人工皮膚マトリックス市場規模を算出する際に考慮しました。

・人工皮膚マトリックス市場の概要
- 人工皮膚マトリックスの種類別セグメント
- 世界の人工皮膚マトリックス市場規模：タイプ別分析（動物由来、ヒト由来）
- 人工皮膚マトリックスの用途別セグメント
- 世界の人工皮膚マトリックス市場規模：用途別分析（病院、診療所）
- 世界の人工皮膚マトリックス市場規模予測（2018年-2029年）

・人工皮膚マトリックス市場の成長トレンド
- 人工皮膚マトリックスの地域別市場規模（2018年-2029年）
- 人工皮膚マトリックス市場ダイナミクス
- 人工皮膚マトリックスの業界動向
- 人工皮膚マトリックス市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：動物由来、ヒト由来
- 世界の人工皮膚マトリックスのタイプ別市場規模（2018年-2023年）
- 世界の人工皮膚マトリックスのタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所
- 世界の人工皮膚マトリックスの用途別市場規模（2018年-2023年）
- 世界の人工皮膚マトリックスの用途別市場規模（2024年-2029年）

・人工皮膚マトリックスの地域別市場規模
- 北米の人工皮膚マトリックス市場規模（2018年-2029年）
- 米国の人工皮膚マトリックス市場規模（2018年-2029年）
- ヨーロッパの人工皮膚マトリックス市場規模（2018年-2029年）
- アジア太平洋の人工皮膚マトリックス市場規模（2018年-2029年）
- 中国の人工皮膚マトリックス市場規模（2018年-2029年）
- 日本の人工皮膚マトリックス市場規模（2018年-2029年）
- 韓国の人工皮膚マトリックス市場規模（2018年-2029年）
- インドの人工皮膚マトリックス市場規模（2018年-2029年）
- オーストラリアの人工皮膚マトリックス市場規模（2018年-2029年）
- 中南米の人工皮膚マトリックス市場規模（2018年-2029年）
- 中東・アフリカの人工皮膚マトリックス市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
MTF Biologics、Allosource、Parametrics Medical、LifeNet Health、Gunze、Tissue Regenix、Zimmer Biomet、Integra LifeSciences、Organogenesis、Flower Orthopedics、Promethean、Wright Medical Group、Aziyo Biologics、RTI Surgical、MiMedx Group、Tides Medical、Ventris Medical、Vivex Biomedical、Aedicell、Amniox Medical、StimLabs、Skye Biologics

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Artificial Dermal Matrix market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Artificial Dermal Matrix is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Artificial Dermal Matrix is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Artificial Dermal Matrix in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Artificial Dermal Matrix include MTF Biologics, Allosource, Parametrics Medical, LifeNet Health, Gunze, Tissue Regenix, Zimmer Biomet, Integra LifeSciences and Organogenesis, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Dermal Matrix, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Dermal Matrix.
The Artificial Dermal Matrix market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Dermal Matrix market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Dermal Matrix companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics
Segment by Type
From Animal Source
From Human Source
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Dermal Matrix companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Dermal Matrix Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 From Animal Source
1.2.3 From Human Source
1.3 Market by Application
1.3.1 Global Artificial Dermal Matrix Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Dermal Matrix Market Perspective (2018-2029)
2.2 Artificial Dermal Matrix Growth Trends by Region
2.2.1 Global Artificial Dermal Matrix Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Dermal Matrix Historic Market Size by Region (2018-2023)
2.2.3 Artificial Dermal Matrix Forecasted Market Size by Region (2024-2029)
2.3 Artificial Dermal Matrix Market Dynamics
2.3.1 Artificial Dermal Matrix Industry Trends
2.3.2 Artificial Dermal Matrix Market Drivers
2.3.3 Artificial Dermal Matrix Market Challenges
2.3.4 Artificial Dermal Matrix Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Dermal Matrix Players by Revenue
3.1.1 Global Top Artificial Dermal Matrix Players by Revenue (2018-2023)
3.1.2 Global Artificial Dermal Matrix Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Dermal Matrix Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Dermal Matrix Revenue
3.4 Global Artificial Dermal Matrix Market Concentration Ratio
3.4.1 Global Artificial Dermal Matrix Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Dermal Matrix Revenue in 2022
3.5 Artificial Dermal Matrix Key Players Head office and Area Served
3.6 Key Players Artificial Dermal Matrix Product Solution and Service
3.7 Date of Enter into Artificial Dermal Matrix Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Dermal Matrix Breakdown Data by Type
4.1 Global Artificial Dermal Matrix Historic Market Size by Type (2018-2023)
4.2 Global Artificial Dermal Matrix Forecasted Market Size by Type (2024-2029)
5 Artificial Dermal Matrix Breakdown Data by Application
5.1 Global Artificial Dermal Matrix Historic Market Size by Application (2018-2023)
5.2 Global Artificial Dermal Matrix Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Dermal Matrix Market Size (2018-2029)
6.2 North America Artificial Dermal Matrix Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Dermal Matrix Market Size by Country (2018-2023)
6.4 North America Artificial Dermal Matrix Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Dermal Matrix Market Size (2018-2029)
7.2 Europe Artificial Dermal Matrix Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Dermal Matrix Market Size by Country (2018-2023)
7.4 Europe Artificial Dermal Matrix Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Dermal Matrix Market Size (2018-2029)
8.2 Asia-Pacific Artificial Dermal Matrix Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Dermal Matrix Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Dermal Matrix Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Dermal Matrix Market Size (2018-2029)
9.2 Latin America Artificial Dermal Matrix Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Dermal Matrix Market Size by Country (2018-2023)
9.4 Latin America Artificial Dermal Matrix Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Dermal Matrix Market Size (2018-2029)
10.2 Middle East & Africa Artificial Dermal Matrix Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Dermal Matrix Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Dermal Matrix Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MTF Biologics
11.1.1 MTF Biologics Company Detail
11.1.2 MTF Biologics Business Overview
11.1.3 MTF Biologics Artificial Dermal Matrix Introduction
11.1.4 MTF Biologics Revenue in Artificial Dermal Matrix Business (2018-2023)
11.1.5 MTF Biologics Recent Development
11.2 Allosource
11.2.1 Allosource Company Detail
11.2.2 Allosource Business Overview
11.2.3 Allosource Artificial Dermal Matrix Introduction
11.2.4 Allosource Revenue in Artificial Dermal Matrix Business (2018-2023)
11.2.5 Allosource Recent Development
11.3 Parametrics Medical
11.3.1 Parametrics Medical Company Detail
11.3.2 Parametrics Medical Business Overview
11.3.3 Parametrics Medical Artificial Dermal Matrix Introduction
11.3.4 Parametrics Medical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.3.5 Parametrics Medical Recent Development
11.4 LifeNet Health
11.4.1 LifeNet Health Company Detail
11.4.2 LifeNet Health Business Overview
11.4.3 LifeNet Health Artificial Dermal Matrix Introduction
11.4.4 LifeNet Health Revenue in Artificial Dermal Matrix Business (2018-2023)
11.4.5 LifeNet Health Recent Development
11.5 Gunze
11.5.1 Gunze Company Detail
11.5.2 Gunze Business Overview
11.5.3 Gunze Artificial Dermal Matrix Introduction
11.5.4 Gunze Revenue in Artificial Dermal Matrix Business (2018-2023)
11.5.5 Gunze Recent Development
11.6 Tissue Regenix
11.6.1 Tissue Regenix Company Detail
11.6.2 Tissue Regenix Business Overview
11.6.3 Tissue Regenix Artificial Dermal Matrix Introduction
11.6.4 Tissue Regenix Revenue in Artificial Dermal Matrix Business (2018-2023)
11.6.5 Tissue Regenix Recent Development
11.7 Zimmer Biomet
11.7.1 Zimmer Biomet Company Detail
11.7.2 Zimmer Biomet Business Overview
11.7.3 Zimmer Biomet Artificial Dermal Matrix Introduction
11.7.4 Zimmer Biomet Revenue in Artificial Dermal Matrix Business (2018-2023)
11.7.5 Zimmer Biomet Recent Development
11.8 Integra LifeSciences
11.8.1 Integra LifeSciences Company Detail
11.8.2 Integra LifeSciences Business Overview
11.8.3 Integra LifeSciences Artificial Dermal Matrix Introduction
11.8.4 Integra LifeSciences Revenue in Artificial Dermal Matrix Business (2018-2023)
11.8.5 Integra LifeSciences Recent Development
11.9 Organogenesis
11.9.1 Organogenesis Company Detail
11.9.2 Organogenesis Business Overview
11.9.3 Organogenesis Artificial Dermal Matrix Introduction
11.9.4 Organogenesis Revenue in Artificial Dermal Matrix Business (2018-2023)
11.9.5 Organogenesis Recent Development
11.10 Flower Orthopedics
11.10.1 Flower Orthopedics Company Detail
11.10.2 Flower Orthopedics Business Overview
11.10.3 Flower Orthopedics Artificial Dermal Matrix Introduction
11.10.4 Flower Orthopedics Revenue in Artificial Dermal Matrix Business (2018-2023)
11.10.5 Flower Orthopedics Recent Development
11.11 Promethean
11.11.1 Promethean Company Detail
11.11.2 Promethean Business Overview
11.11.3 Promethean Artificial Dermal Matrix Introduction
11.11.4 Promethean Revenue in Artificial Dermal Matrix Business (2018-2023)
11.11.5 Promethean Recent Development
11.12 Wright Medical Group
11.12.1 Wright Medical Group Company Detail
11.12.2 Wright Medical Group Business Overview
11.12.3 Wright Medical Group Artificial Dermal Matrix Introduction
11.12.4 Wright Medical Group Revenue in Artificial Dermal Matrix Business (2018-2023)
11.12.5 Wright Medical Group Recent Development
11.13 Aziyo Biologics
11.13.1 Aziyo Biologics Company Detail
11.13.2 Aziyo Biologics Business Overview
11.13.3 Aziyo Biologics Artificial Dermal Matrix Introduction
11.13.4 Aziyo Biologics Revenue in Artificial Dermal Matrix Business (2018-2023)
11.13.5 Aziyo Biologics Recent Development
11.14 RTI Surgical
11.14.1 RTI Surgical Company Detail
11.14.2 RTI Surgical Business Overview
11.14.3 RTI Surgical Artificial Dermal Matrix Introduction
11.14.4 RTI Surgical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.14.5 RTI Surgical Recent Development
11.15 MiMedx Group
11.15.1 MiMedx Group Company Detail
11.15.2 MiMedx Group Business Overview
11.15.3 MiMedx Group Artificial Dermal Matrix Introduction
11.15.4 MiMedx Group Revenue in Artificial Dermal Matrix Business (2018-2023)
11.15.5 MiMedx Group Recent Development
11.16 Tides Medical
11.16.1 Tides Medical Company Detail
11.16.2 Tides Medical Business Overview
11.16.3 Tides Medical Artificial Dermal Matrix Introduction
11.16.4 Tides Medical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.16.5 Tides Medical Recent Development
11.17 Ventris Medical
11.17.1 Ventris Medical Company Detail
11.17.2 Ventris Medical Business Overview
11.17.3 Ventris Medical Artificial Dermal Matrix Introduction
11.17.4 Ventris Medical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.17.5 Ventris Medical Recent Development
11.18 Vivex Biomedical
11.18.1 Vivex Biomedical Company Detail
11.18.2 Vivex Biomedical Business Overview
11.18.3 Vivex Biomedical Artificial Dermal Matrix Introduction
11.18.4 Vivex Biomedical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.18.5 Vivex Biomedical Recent Development
11.19 Aedicell
11.19.1 Aedicell Company Detail
11.19.2 Aedicell Business Overview
11.19.3 Aedicell Artificial Dermal Matrix Introduction
11.19.4 Aedicell Revenue in Artificial Dermal Matrix Business (2018-2023)
11.19.5 Aedicell Recent Development
11.20 Amniox Medical
11.20.1 Amniox Medical Company Detail
11.20.2 Amniox Medical Business Overview
11.20.3 Amniox Medical Artificial Dermal Matrix Introduction
11.20.4 Amniox Medical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.20.5 Amniox Medical Recent Development
11.21 StimLabs
11.21.1 StimLabs Company Detail
11.21.2 StimLabs Business Overview
11.21.3 StimLabs Artificial Dermal Matrix Introduction
11.21.4 StimLabs Revenue in Artificial Dermal Matrix Business (2018-2023)
11.21.5 StimLabs Recent Development
11.22 Skye Biologics
11.22.1 Skye Biologics Company Detail
11.22.2 Skye Biologics Business Overview
11.22.3 Skye Biologics Artificial Dermal Matrix Introduction
11.22.4 Skye Biologics Revenue in Artificial Dermal Matrix Business (2018-2023)
11.22.5 Skye Biologics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Artificial Dermal Matrix Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of From Animal Source
Table 3. Key Players of From Human Source
Table 4. Global Artificial Dermal Matrix Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Artificial Dermal Matrix Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Artificial Dermal Matrix Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Artificial Dermal Matrix Market Share by Region (2018-2023)
Table 8. Global Artificial Dermal Matrix Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Artificial Dermal Matrix Market Share by Region (2024-2029)
Table 10. Artificial Dermal Matrix Market Trends
Table 11. Artificial Dermal Matrix Market Drivers
Table 12. Artificial Dermal Matrix Market Challenges
Table 13. Artificial Dermal Matrix Market Restraints
Table 14. Global Artificial Dermal Matrix Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Artificial Dermal Matrix Market Share by Players (2018-2023)
Table 16. Global Top Artificial Dermal Matrix Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Dermal Matrix as of 2022)
Table 17. Ranking of Global Top Artificial Dermal Matrix Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Artificial Dermal Matrix Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Artificial Dermal Matrix Product Solution and Service
Table 21. Date of Enter into Artificial Dermal Matrix Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artificial Dermal Matrix Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Artificial Dermal Matrix Revenue Market Share by Type (2018-2023)
Table 25. Global Artificial Dermal Matrix Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Artificial Dermal Matrix Revenue Market Share by Type (2024-2029)
Table 27. Global Artificial Dermal Matrix Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Artificial Dermal Matrix Revenue Market Share by Application (2018-2023)
Table 29. Global Artificial Dermal Matrix Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Artificial Dermal Matrix Revenue Market Share by Application (2024-2029)
Table 31. North America Artificial Dermal Matrix Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Artificial Dermal Matrix Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Artificial Dermal Matrix Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Artificial Dermal Matrix Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Artificial Dermal Matrix Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Artificial Dermal Matrix Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Artificial Dermal Matrix Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Artificial Dermal Matrix Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Artificial Dermal Matrix Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Artificial Dermal Matrix Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Artificial Dermal Matrix Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Artificial Dermal Matrix Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Artificial Dermal Matrix Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Artificial Dermal Matrix Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Artificial Dermal Matrix Market Size by Country (2024-2029) & (US$ Million)
Table 46. MTF Biologics Company Detail
Table 47. MTF Biologics Business Overview
Table 48. MTF Biologics Artificial Dermal Matrix Product
Table 49. MTF Biologics Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 50. MTF Biologics Recent Development
Table 51. Allosource Company Detail
Table 52. Allosource Business Overview
Table 53. Allosource Artificial Dermal Matrix Product
Table 54. Allosource Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 55. Allosource Recent Development
Table 56. Parametrics Medical Company Detail
Table 57. Parametrics Medical Business Overview
Table 58. Parametrics Medical Artificial Dermal Matrix Product
Table 59. Parametrics Medical Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 60. Parametrics Medical Recent Development
Table 61. LifeNet Health Company Detail
Table 62. LifeNet Health Business Overview
Table 63. LifeNet Health Artificial Dermal Matrix Product
Table 64. LifeNet Health Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 65. LifeNet Health Recent Development
Table 66. Gunze Company Detail
Table 67. Gunze Business Overview
Table 68. Gunze Artificial Dermal Matrix Product
Table 69. Gunze Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 70. Gunze Recent Development
Table 71. Tissue Regenix Company Detail
Table 72. Tissue Regenix Business Overview
Table 73. Tissue Regenix Artificial Dermal Matrix Product
Table 74. Tissue Regenix Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 75. Tissue Regenix Recent Development
Table 76. Zimmer Biomet Company Detail
Table 77. Zimmer Biomet Business Overview
Table 78. Zimmer Biomet Artificial Dermal Matrix Product
Table 79. Zimmer Biomet Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 80. Zimmer Biomet Recent Development
Table 81. Integra LifeSciences Company Detail
Table 82. Integra LifeSciences Business Overview
Table 83. Integra LifeSciences Artificial Dermal Matrix Product
Table 84. Integra LifeSciences Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 85. Integra LifeSciences Recent Development
Table 86. Organogenesis Company Detail
Table 87. Organogenesis Business Overview
Table 88. Organogenesis Artificial Dermal Matrix Product
Table 89. Organogenesis Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 90. Organogenesis Recent Development
Table 91. Flower Orthopedics Company Detail
Table 92. Flower Orthopedics Business Overview
Table 93. Flower Orthopedics Artificial Dermal Matrix Product
Table 94. Flower Orthopedics Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 95. Flower Orthopedics Recent Development
Table 96. Promethean Company Detail
Table 97. Promethean Business Overview
Table 98. Promethean Artificial Dermal Matrix Product
Table 99. Promethean Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 100. Promethean Recent Development
Table 101. Wright Medical Group Company Detail
Table 102. Wright Medical Group Business Overview
Table 103. Wright Medical Group Artificial Dermal Matrix Product
Table 104. Wright Medical Group Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 105. Wright Medical Group Recent Development
Table 106. Aziyo Biologics Company Detail
Table 107. Aziyo Biologics Business Overview
Table 108. Aziyo Biologics Artificial Dermal Matrix Product
Table 109. Aziyo Biologics Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 110. Aziyo Biologics Recent Development
Table 111. RTI Surgical Company Detail
Table 112. RTI Surgical Business Overview
Table 113. RTI Surgical Artificial Dermal Matrix Product
Table 114. RTI Surgical Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 115. RTI Surgical Recent Development
Table 116. MiMedx Group Company Detail
Table 117. MiMedx Group Business Overview
Table 118. MiMedx Group Artificial Dermal Matrix Product
Table 119. MiMedx Group Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 120. MiMedx Group Recent Development
Table 121. Tides Medical Company Detail
Table 122. Tides Medical Business Overview
Table 123. Tides Medical Artificial Dermal Matrix Product
Table 124. Tides Medical Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 125. Tides Medical Recent Development
Table 126. Ventris Medical Company Detail
Table 127. Ventris Medical Business Overview
Table 128. Ventris Medical Artificial Dermal Matrix Product
Table 129. Ventris Medical Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 130. Ventris Medical Recent Development
Table 131. Vivex Biomedical Company Detail
Table 132. Vivex Biomedical Business Overview
Table 133. Vivex Biomedical Artificial Dermal Matrix Product
Table 134. Vivex Biomedical Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 135. Vivex Biomedical Recent Development
Table 136. Aedicell Company Detail
Table 137. Aedicell Business Overview
Table 138. Aedicell Artificial Dermal Matrix Product
Table 139. Aedicell Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 140. Aedicell Recent Development
Table 141. Amniox Medical Company Detail
Table 142. Amniox Medical Business Overview
Table 143. Amniox Medical Artificial Dermal Matrix Product
Table 144. Amniox Medical Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 145. Amniox Medical Recent Development
Table 146. StimLabs Company Detail
Table 147. StimLabs Business Overview
Table 148. StimLabs Artificial Dermal Matrix Product
Table 149. StimLabs Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 150. StimLabs Recent Development
Table 151. Skye Biologics Company Detail
Table 152. Skye Biologics Business Overview
Table 153. Skye Biologics Artificial Dermal Matrix Product
Table 154. Skye Biologics Revenue in Artificial Dermal Matrix Business (2018-2023) & (US$ Million)
Table 155. Skye Biologics Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Dermal Matrix Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Artificial Dermal Matrix Market Share by Type: 2022 VS 2029
Figure 3. From Animal Source Features
Figure 4. From Human Source Features
Figure 5. Global Artificial Dermal Matrix Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Artificial Dermal Matrix Market Share by Application: 2022 VS 2029
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Artificial Dermal Matrix Report Years Considered
Figure 10. Global Artificial Dermal Matrix Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Artificial Dermal Matrix Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Artificial Dermal Matrix Market Share by Region: 2022 VS 2029
Figure 13. Global Artificial Dermal Matrix Market Share by Players in 2022
Figure 14. Global Top Artificial Dermal Matrix Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Dermal Matrix as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Artificial Dermal Matrix Revenue in 2022
Figure 16. North America Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Artificial Dermal Matrix Market Share by Country (2018-2029)
Figure 18. United States Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Artificial Dermal Matrix Market Share by Country (2018-2029)
Figure 22. Germany Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Artificial Dermal Matrix Market Share by Region (2018-2029)
Figure 30. China Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Artificial Dermal Matrix Market Share by Country (2018-2029)
Figure 38. Mexico Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Artificial Dermal Matrix Market Share by Country (2018-2029)
Figure 42. Turkey Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Artificial Dermal Matrix Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. MTF Biologics Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 45. Allosource Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 46. Parametrics Medical Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 47. LifeNet Health Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 48. Gunze Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 49. Tissue Regenix Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 50. Zimmer Biomet Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 51. Integra LifeSciences Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 52. Organogenesis Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 53. Flower Orthopedics Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 54. Promethean Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 55. Wright Medical Group Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 56. Aziyo Biologics Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 57. RTI Surgical Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 58. MiMedx Group Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 59. Tides Medical Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 60. Ventris Medical Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 61. Vivex Biomedical Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 62. Aedicell Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 63. Amniox Medical Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 64. StimLabs Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 65. Skye Biologics Revenue Growth Rate in Artificial Dermal Matrix Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 人工真皮の世界市場2023年：動物由来、ヒト由来
  • 同種移植真皮の世界市場2023年：動物由来、ヒト由来
  • 腸溶カプセルコーティングの世界市場2023年：動物由来、ベジタリアンベース
  • 食品用キシラナーゼの世界市場2023年：動物由来、植物由来、微生物由来
  • 人工臓器＆組織の世界市場2023年：人工腎臓、人工心臓＆補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、バイオニックハンド＆人工装具、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7632 )"人工皮膚マトリックスの世界市場2023年：動物由来、ヒト由来" (英文：Global Artificial Dermal Matrix Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。